This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1959:15:300-7.

doi: 10.1159/000229055.

Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine

PMID: 14446408
DOI: 10.1159/000229055

Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine

F SICUTERI. Int Arch Allergy Appl Immunol. 1959.

. 1959:15:300-7.

doi: 10.1159/000229055.

Author

PMID: 14446408
DOI: 10.1159/000229055

No abstract available

PubMed Disclaimer

Similar articles

[First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
SICUTERI F. SICUTERI F. Prog Med (Napoli). 1960 Jan 15;16:20-2. Prog Med (Napoli). 1960. PMID: 14446409 Italian. No abstract available.
Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
FRIEDMAN AP, LOSIN S. FRIEDMAN AP, et al. Arch Neurol. 1961 Mar;4:241-5. doi: 10.1001/archneur.1961.00450090007002. Arch Neurol. 1961. PMID: 13701987 No abstract available.
THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
CROWTHER DL. CROWTHER DL. Med Exp Int J Exp Med. 1964;10:137-43. doi: 10.1159/000135408. Med Exp Int J Exp Med. 1964. PMID: 14129849 No abstract available.
Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
SICUTERI F. SICUTERI F. Med Exp Int J Exp Med. 1960;2:36-9. doi: 10.1159/000134839. Med Exp Int J Exp Med. 1960. PMID: 14446407 No abstract available.
Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
SICUTERI F, MICHELACCI S, FRANCHI G. SICUTERI F, et al. Int Arch Allergy Appl Immunol. 1959;15:291-9. doi: 10.1159/000229054. Int Arch Allergy Appl Immunol. 1959. PMID: 14446403 No abstract available.

See all similar articles

Cited by

Urinary histamine excretion in migraine and cluster headache. Further observations.
Sjaastad O, Sjaastad OV. Sjaastad O, et al. J Neurol. 1977 Sep 12;216(2):91-104. doi: 10.1007/BF00312943. J Neurol. 1977. PMID: 72805
Comparative trial of serotonin antagonists in the management of migraine.
Lance JW, Anthony M, Somerville B. Lance JW, et al. Br Med J. 1970 May 9;2(5705):327-30. doi: 10.1136/bmj.2.5705.327. Br Med J. 1970. PMID: 4393372 Free PMC article. Clinical Trial.
Preclinical neuropharmacology of naratriptan.
Lambert GA. Lambert GA. CNS Drug Rev. 2005 Autumn;11(3):289-316. doi: 10.1111/j.1527-3458.2005.tb00048.x. CNS Drug Rev. 2005. PMID: 16389295 Free PMC article. Review.
Evidence-based treatments for cluster headache.
Gooriah R, Buture A, Ahmed F. Gooriah R, et al. Ther Clin Risk Manag. 2015 Nov 9;11:1687-96. doi: 10.2147/TCRM.S94193. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 26635477 Free PMC article. Review.
Pain as a symptom in depressive disorders and its relationship to platelet monoamine oxidase activity.
von Knorring L, Perris C, Oreland L, Eisemann M, Eriksson U, Perris H. von Knorring L, et al. J Neural Transm. 1984;60(1):1-9. doi: 10.1007/BF01254760. J Neural Transm. 1984. PMID: 6207267

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions